{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T20:34:25Z","timestamp":1772915665220,"version":"3.50.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,7,24]],"date-time":"2009-07-24T00:00:00Z","timestamp":1248393600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1038\/eye.2009.192","type":"journal-article","created":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T15:34:50Z","timestamp":1249140890000},"page":"600-607","source":"Crossref","is-referenced-by-count":58,"title":["Long-term efficacy of botulinum toxin A for treatment of blepharospasm, hemifacial spasm, and spastic entropion: a multicentre study using two drug-dose escalation indexes"],"prefix":"10.1038","volume":"24","author":[{"given":"S","family":"Cillino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Raimondi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Gu\u00e9pratte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Damiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Cillino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Di Pace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Casuccio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,7,24]]},"reference":[{"key":"BFeye2009192_CR1","first-page":"371","volume":"16","author":"J Jankovic","year":"1984","unstructured":"Jankovic J, Orman J . Blepharospasm: demographic and clinical survey of 250 patients. Ann Ophthalmol 1984; 16: 371\u2013376.","journal-title":"Ann Ophthalmol"},{"key":"BFeye2009192_CR2","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1136\/jnnp.51.6.767","volume":"51","author":"F Grandas","year":"1988","unstructured":"Grandas F, Elston J, Quinn N, Marsden CD . Blepharospasm: a review of 264 patients. J Neurol Neurosurg Psychiatry 1988; 51: 767\u2013772.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFeye2009192_CR3","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1002\/mds.10142","volume":"17","author":"JL Vitek","year":"2002","unstructured":"Vitek JL . Pathophysiology of dystonia: a neuronal model. Mov Disord 2002; 17: S49\u2013S62.","journal-title":"Mov Disord"},{"key":"BFeye2009192_CR4","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1001\/jama.1982.03330230060037","volume":"248","author":"J Jankovic","year":"1982","unstructured":"Jankovic J, Havins WE, Wilkins RB . Blinking and blepharospasm. Mechanism, diagnosis, and management. JAMA 1982; 248: 3160\u20133164.","journal-title":"JAMA"},{"key":"BFeye2009192_CR5","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1600-0404.2004.00357.x","volume":"111","author":"J Reimer","year":"2005","unstructured":"Reimer J, Gilg K, Karow A, Esser J, Franke GH . Health-related quality of life in blepharospasm or hemifacial spasm. Acta Neurol Scand 2005; 111: 64\u201370.","journal-title":"Acta Neurol Scand"},{"key":"BFeye2009192_CR6","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s004150070094","volume":"247","author":"Epidemiological Study of Dystonia in Europe (ESDE) Collaborative Group","year":"2000","unstructured":"Epidemiological Study of Dystonia in Europe (ESDE) Collaborative Group. A prevalence study of primary dystonia in eight European countries. J Neurol 2000; 247: 787\u2013792.","journal-title":"J Neurol"},{"key":"BFeye2009192_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/mds.1275","volume":"17","author":"G Defazio","year":"2002","unstructured":"Defazio G, Livrea P . Epidemiology of primary blepharospasm. Mov Disord 2002; 17: 7\u201312.","journal-title":"Mov Disord"},{"key":"BFeye2009192_CR8","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1002\/mds.21084","volume":"21","author":"G Cossu","year":"2006","unstructured":"Cossu G, Mereu A, Deriu M, Melis M, Molari A, Melis G et al. Prevalence of primary blepharospasm in Sardinia, Italy: a service-based survey. Mov Disord 2006; 21: 2005\u20132008.","journal-title":"Mov Disord"},{"key":"BFeye2009192_CR9","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s00702-007-0768-7","volume":"115","author":"C Kenney","year":"2008","unstructured":"Kenney C, Jankovic J . Botulinum toxin in the treatment of blepharospasm and hemifacial spasm. J Neural Transm 2008; 115: 585\u2013591.","journal-title":"J Neural Transm"},{"key":"BFeye2009192_CR10","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/00002341-199809000-00002","volume":"14","author":"RL Anderson","year":"1998","unstructured":"Anderson RL, Patel BC, Holds JB, Jordan DR . Blepharospasm: past, present and future. Ophthal Plast Reconstr Surg 1998; 14: 305\u2013317.","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"BFeye2009192_CR11","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/S0161-6420(80)35127-0","volume":"87","author":"AB Scott","year":"1980","unstructured":"Scott AB . Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology 1980; 87: 1044\u20131049.","journal-title":"Ophthalmology"},{"key":"BFeye2009192_CR12","unstructured":"FDA Center for Biologics Evaluation and Research. Botulinum toxin type A (Botox), Allergan, Inc. Product approval information, licensing action, 2000a. Available at: http:\/\/www.fda.gov\/cder\/foi\/appletter\/2000\/botaller122100L.htm ."},{"key":"BFeye2009192_CR13","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1001\/archopht.1991.01080030098047","volume":"109","author":"JD Porter","year":"1991","unstructured":"Porter JD, Strebeck S, Capra NF . Botulinum-induced changes in monkey eyelid muscle. Comparison with change seen in extraocular muscle. Arch Ophthalmol 1991; 109: 396\u2013404.","journal-title":"Arch Ophthalmol"},{"key":"BFeye2009192_CR14","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1016\/S0161-6420(93)31384-9","volume":"100","author":"RM Siatkowski","year":"1993","unstructured":"Siatkowski RM, Tyutyunikov A, Biglan AW, Scalise D, Genovese C, Raikow RB et al. Serum antibody production to botulinum A toxin. Ophthalmology 1993; 100: 1861\u20131866.","journal-title":"Ophthalmology"},{"key":"BFeye2009192_CR15","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1067\/mjd.2000.105567","volume":"43","author":"W Huang","year":"2000","unstructured":"Huang W, Foster JA, Rogachefsky AS . Pharmacology of botulinum toxin. J Am Acad Dermatol 2000; 43: 249\u2013259.","journal-title":"J Am Acad Dermatol"},{"key":"BFeye2009192_CR16","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0002-9394(03)00075-8","volume":"136","author":"M Snir","year":"2003","unstructured":"Snir M, Weinberger D, Bourla D, Kristal-Shalit O, Dotan G, Axer-Siegel R . Quantitative changes in botulinum toxin a treatment over time in patients with essential blepharospasm and idiopathic hemifacial spasm. Am J Ophthalmol 2003; 136: 99\u2013105.","journal-title":"Am J Ophthalmol"},{"key":"BFeye2009192_CR17","doi-asserted-by":"crossref","unstructured":"Costa J, Esp\u00edrito-Santo C, Borges A, Ferreira JJ, Coelho M, Moore P et al. Botulinum toxin type A therapy for blepharospasm. Cochrane Database Syst Rev 2005; (1): CD004900.","DOI":"10.1002\/14651858.CD004899.pub2"},{"key":"BFeye2009192_CR18","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1212\/WNL.35.10.1499","volume":"35","author":"JA Mauriello","year":"1985","unstructured":"Mauriello JA . Blepharospasm, Meige syndrome, and hemifacial spasm: treatment with botulinum toxin. Neurology 1985; 35: 1499\u20131500.","journal-title":"Neurology"},{"key":"BFeye2009192_CR19","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1001\/archopht.1985.01050030043017","volume":"103","author":"AB Scott","year":"1985","unstructured":"Scott AB, Kennedy RA, Stubbs HA . Botulinum A toxin injection as a treatment for blepharospasm. Arch Ophthalmol 1985; 103: 347\u2013350.","journal-title":"Arch Ophthalmol"},{"key":"BFeye2009192_CR20","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1097\/00002826-198610000-00002","volume":"9","author":"DA Cohen","year":"1986","unstructured":"Cohen DA, Savino PJ, Stern MB, Hurtig HI . Botulinum injection therapy for blepharospasm: a review and report of 75 patients. Clin Neuropharmacol 1986; 9: 415\u2013429.","journal-title":"Clin Neuropharmacol"},{"key":"BFeye2009192_CR21","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1001\/archneur.1986.00520040060020","volume":"43","author":"JJ Dutton","year":"1986","unstructured":"Dutton JJ, Buckley EG . Botulinum toxin in the management of blepharospasm. Arch Neurol 1986; 43: 380\u2013382.","journal-title":"Arch Neurol"},{"key":"BFeye2009192_CR22","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1136\/bjo.71.9.664","volume":"71","author":"JS Elston","year":"1987","unstructured":"Elston JS . Long-term results of treatment of idiopathic blepharospasm with botulinum toxin injections. Br J Ophthalmol 1987; 71: 664\u2013668.","journal-title":"Br J Ophthalmol"},{"key":"BFeye2009192_CR23","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0161-6420(87)33338-X","volume":"17","author":"PF Engstrom","year":"1987","unstructured":"Engstrom PF, Arnoult JB, Mazow ML, Prager TC, Wilkins RB, Byrd WA et al. Effectiveness of botulinum toxin therapy for essential blepharospasm. Ophthalmology 1987; 17: 971\u2013975.","journal-title":"Ophthalmology"},{"key":"BFeye2009192_CR24","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/S0161-6420(88)32977-5","volume":"95","author":"JJ Dutton","year":"1988","unstructured":"Dutton JJ, Buckley EG . Long-term results and complications of botulinum A toxin in the treatment of blepharospasm. Ophthalmology 1988; 95: 1529\u20131534.","journal-title":"Ophthalmology"},{"key":"BFeye2009192_CR25","first-page":"133","volume":"26","author":"JD Taylor","year":"1991","unstructured":"Taylor JD, Kraft SP, Kazdan MS, Flanders M, Cadera W, Orton RB . Treatment of blepharospasm and hemifacial spasm with botulinum A toxin: a Canadian multicentre study. Can J Ophthalmol 1991; 26: 133\u2013138.","journal-title":"Can J Ophthalmol"},{"key":"BFeye2009192_CR26","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1212\/WNL.44.12.2401","volume":"44","author":"Subcommittee of the American Academy of Neurology","year":"1994","unstructured":"Subcommittee of the American Academy of Neurology. Training guidelines for the use of botulinum toxin for the treatment of neurologic disorders. Report of the Therapeutics and Technology Assessment. Neurology 1994; 44: 2401\u20132403.","journal-title":"Neurology"},{"key":"BFeye2009192_CR27","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0039-6257(97)81995-9","volume":"41","author":"JJ Dutton","year":"1996","unstructured":"Dutton JJ . Botulinum-A toxin in the treatment of craniocervical muscle spasms: short- and long-term, local and systemic effects. Surv Ophthalmol 1996; 41: 51\u201365.","journal-title":"Surv Ophthalmol"},{"key":"BFeye2009192_CR28","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1177\/112067210301300401","volume":"13","author":"P Calace","year":"2003","unstructured":"Calace P, Cortese G, Piscopo R, Della Volpe G, Gagliardi V, Magli A et al. Treatment of blepharospasm with botulinum neurotoxin type A: longterm results. Eur J Ophthalmol 2003; 13: 331\u2013336.","journal-title":"Eur J Ophthalmol"},{"key":"BFeye2009192_CR29","first-page":"303","volume":"113","author":"P Roggenk\u00e4mper","year":"2006","unstructured":"Roggenk\u00e4mper P, Jost WH, Bihari K, Comes G, Grafe S . for the NT 201 Blepharospasm Study Team. Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm. J Neural Transm 2006; 113: 303\u2013312.","journal-title":"for the NT 201 Blepharospasm Study Team"},{"key":"BFeye2009192_CR30","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/S0161-6420(86)33641-8","volume":"93","author":"BR Frueh","year":"1986","unstructured":"Frueh BR, Musch DC . Treatment of facial spasm with botulinum toxin. An interim report. Ophthalmology 1986; 93: 917\u2013923.","journal-title":"Ophthalmology"},{"key":"BFeye2009192_CR31","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/00002341-198601060-00005","volume":"2","author":"RS Gonnering","year":"1986","unstructured":"Gonnering RS . Treatment of hemifacial spasm with botulinum A toxin. Results and rationale. Ophthal Plast Reconstr Surg 1986; 2: 143\u2013146.","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"BFeye2009192_CR32","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1001\/archneur.1990.00530110095023","volume":"47","author":"RG Auger","year":"1990","unstructured":"Auger RG, Whisnant JP . Hemifacial spasm in Rochester and Olmsted County, Minnesota, 1960 to 1984. Arch Neurol 1990; 47: 1233\u20131234.","journal-title":"Arch Neurol"},{"key":"BFeye2009192_CR33","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1002\/mds.870090310","volume":"9","author":"F Micheli","year":"1994","unstructured":"Micheli F, Scorticati MC, Gatto E, Cersosimo G, Adi J . Familial hemifacial spasm. Mov Disord 1994; 9: 330\u2013332.","journal-title":"Mov Disord"},{"key":"BFeye2009192_CR34","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1002\/(SICI)1097-4598(199812)21:12<1740::AID-MUS17>3.0.CO;2-V","volume":"21","author":"A Wang","year":"1998","unstructured":"Wang A, Jankovic J . Hemifacial spasm: clinical findings and treatment. Muscle Nerve 1998; 21: 1740\u20131747.","journal-title":"Muscle Nerve"},{"key":"BFeye2009192_CR35","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1002\/mus.880150909","volume":"15","author":"DM Yoshimura","year":"1992","unstructured":"Yoshimura DM, Aminoff MJ, Tami TA, Scott AB . Treatment of hemifacial spasm with botulinum toxin. Muscle Nerve 1992; 15: 1045\u20131049.","journal-title":"Muscle Nerve"},{"key":"BFeye2009192_CR36","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/BF00839203","volume":"239","author":"JS Elston","year":"1992","unstructured":"Elston JS . The management of blepharospasm and hemifacial spasm. J Neurol 1992; 239: 5\u20138.","journal-title":"J Neurol"},{"key":"BFeye2009192_CR37","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1159\/000116961","volume":"33","author":"M Flanders","year":"1993","unstructured":"Flanders M, Chin D, Boghen D . Botulinum toxin: preferred treatment for hemifacial spasm. Eur Neurol 1993; 33: 316\u2013319.","journal-title":"Eur Neurol"},{"key":"BFeye2009192_CR38","doi-asserted-by":"crossref","unstructured":"Costa J, Esp\u00edrito-Santo C, Borges A, Ferreira JJ, Coelho M, Moore P et al. Botulinum toxin type A therapy for hemifacial spasm. Cochrane Database Syst Rev 2005; (1): CD004899.","DOI":"10.1002\/14651858.CD004899.pub2"},{"key":"BFeye2009192_CR39","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.survophthal.2006.10.003","volume":"52","author":"JJ Dutton","year":"2007","unstructured":"Dutton JJ, Fowler AM . Botulinum toxin in ophthalmology. Surv Ophthalmol 2007; 52: 13\u201331.","journal-title":"Surv Ophthalmol"},{"key":"BFeye2009192_CR40","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/0303-8467(96)00025-X","volume":"98","author":"JA Mauriello","year":"1996","unstructured":"Mauriello JA, Leone T, Dhillon S, Pakeman B, Mostafavi R, Yepez MC . Treatment choices of 119 patients with hemifacial spasm over 11 years. Clin Neurol Neurosurg 1996; 98: 213\u2013216.","journal-title":"Clin Neurol Neurosurg"},{"key":"BFeye2009192_CR41","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1136\/jnnp.64.6.751","volume":"64","author":"S Jitpimolmard","year":"1998","unstructured":"Jitpimolmard S, Tiamkao S, Laopaiboon M . Long term results of botulinum toxin type A in the treatment of hemifacial spasm: a report of 175 cases. J Neurol Neurosurg Psychiatry 1998; 64: 751\u2013757.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFeye2009192_CR42","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1017\/S0317167100026159","volume":"14","author":"J Carruthers","year":"1987","unstructured":"Carruthers J, Stubbs HA . Botulinum toxin for benign essential blepharospasm, hemifacial spasm and age-related lower eyelid entropion. Can J Neurol Sci 1987; 14: 42\u201345.","journal-title":"Can J Neurol Sci"},{"key":"BFeye2009192_CR43","first-page":"105","volume":"224","author":"A Neetens","year":"1987","unstructured":"Neetens A, Rubbens MC, Smet H . Botulinum A-toxin treatment of spasmodic entropion of the lower eyelid. Bull Soc Belge Ophtalmol 1987; 224: 105\u2013109.","journal-title":"Bull Soc Belge Ophtalmol"},{"key":"BFeye2009192_CR44","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1136\/bjo.72.5.361","volume":"72","author":"JR Clarke","year":"1988","unstructured":"Clarke JR, Spalton DJ . Treatment of senile entropion with botulinum toxin. Br J Ophthalmol 1988; 72: 361\u2013362.","journal-title":"Br J Ophthalmol"},{"key":"BFeye2009192_CR45","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/eye.1997.128","volume":"11","author":"DH Steel","year":"1997","unstructured":"Steel DH, Hoh HB, Harrad RA, Collins CR . Botulinum toxin for the temporary treatment of involutional lower lid entropion: a clinical and morphological study. Eye 1997; 11: 472\u2013475.","journal-title":"Eye"},{"key":"BFeye2009192_CR46","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.parkreldis.2007.03.006","volume":"13","author":"S Ochudlo","year":"2007","unstructured":"Ochudlo S, Bryniarski P, Opala G . Botulinum toxin improves the quality of life and reduces the intensification of depressive symptoms in patients with blepharospasm. Parkinsonism Relat Disord 2007; 13: 505\u2013508.","journal-title":"Parkinsonism Relat Disord"},{"key":"BFeye2009192_CR47","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1007\/s00115-008-2486-2","volume":"79","author":"T Vogt","year":"2008","unstructured":"Vogt T, L\u00fcssi F, Paul A, Urban P . Long-term therapy of focal dystonia and facial hemispasm with botulinum toxin A. Nervenarzt 2008; 79: 912\u2013917.","journal-title":"Nervenarzt"},{"key":"BFeye2009192_CR48","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1159\/000047963","volume":"47","author":"D Dressler","year":"2002","unstructured":"Dressler D, M\u00fcnchau A, Bhatia KP, Quinn NP, Bigalke H . Antibody-induced botulinum toxin therapy failure: can it be overcome by increased botulinum toxin doses? Eur Neurol 2002; 47: 118\u2013121.","journal-title":"Eur Neurol"},{"key":"BFeye2009192_CR49","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/mds.870090216","volume":"9","author":"P Greene","year":"1994","unstructured":"Greene P, Fahn S . Development of resistance to Botulinum toxin type A in patients with torticollis. Mov Disord 1994; 9: 213\u2013217.","journal-title":"Mov Disord"},{"key":"BFeye2009192_CR50","first-page":"219","volume":"19","author":"MZ Atassi","year":"1999","unstructured":"Atassi MZ, Oshima M . Structure, activity and immune recognition of botulinum neurotoxins. Crit Rev Immunol 1999; 19: 219\u2013260.","journal-title":"Crit Rev Immunol"},{"key":"BFeye2009192_CR51","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/j.1442-9071.2006.01236.x","volume":"34","author":"AL Pang","year":"2006","unstructured":"Pang AL, O\u2019Day J . Use of high-dose botulinum A toxin in benign essential blepharospasm: is too high too much? Clin Experiment Ophthalmol 2006; 34: 441\u2013444.","journal-title":"Clin Experiment Ophthalmol"},{"key":"BFeye2009192_CR52","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/j.ophtha.2006.03.055","volume":"113","author":"RL Levy","year":"2006","unstructured":"Levy RL, Berman D, Parikh M, Miller NR . Supramaximal doses of botulinum toxin for refractory blepharospasm. Ophthalmology 2006; 113: 1665\u20131668.","journal-title":"Ophthalmology"},{"key":"BFeye2009192_CR53","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/S0885-3924(96)00302-8","volume":"13","author":"S Mercadante","year":"1997","unstructured":"Mercadante S, Dardanoni G, Salvaggio L, Armata MG, Agnello A . Monitoring of opioid therapy in advanced cancer pain patients. J Pain Symptom Manage 1997; 13: 204\u2013212.","journal-title":"J Pain Symptom Manage"},{"key":"BFeye2009192_CR54","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/BF02083302","volume":"18","author":"A Berardelli","year":"1997","unstructured":"Berardelli A, Abbruzzese G, Bertolasi L, Cantarella G, Carella F, Curr\u00e0 A et al. Guidelines for the therapeutic use of botulinum toxin in movement disorders. Italian Study Group for Movement Disorders, Italian Society of Neurology. Ital J Neurol Sci 1997; 18: 261\u2013269.","journal-title":"Ital J Neurol Sci"},{"key":"BFeye2009192_CR55","first-page":"345","volume-title":"Surgical Management of Strabismus. An Atlas of Strabismus Surgery","author":"EM Helveston","year":"1993","unstructured":"Helveston EM . Surgical Management of Strabismus. An Atlas of Strabismus Surgery, 4th ed. St Louis: CV Mosby, 1993, pp 345\u2013354."},{"key":"BFeye2009192_CR56","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/S0008-4182(01)80084-3","volume":"36","author":"GT Drummond","year":"2001","unstructured":"Drummond GT, Hinz BJ . Botulinum toxin for blepharospasm and hemifacial spasm: stability of duration of effect and dosage over time. Can J Ophthalmol 2001; 36: 398\u2013403.","journal-title":"Can J Ophthalmol"},{"key":"BFeye2009192_CR57","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1016\/S0161-6420(95)30757-9","volume":"102","author":"JR Ainsworth","year":"1995","unstructured":"Ainsworth JR, Kraft SP . Long-term changes in duration of relief with botulinum toxin treatment of essential blepharospasm and hemifacial spasm. Ophthalmology 1995; 102: 2036\u20132040.","journal-title":"Ophthalmology"},{"key":"BFeye2009192_CR58","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1001\/archneur.59.3.418","volume":"59","author":"G Defazio","year":"2002","unstructured":"Defazio G, Abbruzzese G, Girlanda P, Vacca L, Curr\u00e0 A, De Salvia R et al. Botulinum toxin A treatment for primary hemifacial spasm: a 10-year multicenter study. Arch Neurol 2002; 59: 418\u2013420.","journal-title":"Arch Neurol"},{"key":"BFeye2009192_CR59","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00347-007-1592-z","volume":"104","author":"B Wabbels","year":"2007","unstructured":"Wabbels B, F\u00f6rl M . Botulinum toxin treatment for crocodile tears, spastic entropion and for dysthyroid upper eyelid retraction. Ophthalmologe 2007; 104: 771\u2013776.","journal-title":"Ophthalmologe"},{"key":"BFeye2009192_CR60","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jpainsymman.2007.02.044","volume":"35","author":"SS Lowe","year":"2008","unstructured":"Lowe SS, Nekolaichuk CL, Fainsinger RL, Lawlor PG . Should the rate of opioid dose escalation be included as a feature in a cancer pain classification system? J Pain Symptom Manage 2008; 35: 51\u201357.","journal-title":"J Pain Symptom Manage"},{"key":"BFeye2009192_CR61","first-page":"407","volume":"14","author":"D Truong","year":"2008","unstructured":"Truong D, Comella C, Fernandez HH, Ondo WG . Dysport Benign Essential Blepharospasm Study Group. Efficacy and safety of purified botulinum toxin type A (Dysport) for the treatment of benign essential blepharospasm: a randomized, placebo-controlled, phase II trial. Parkinsonism Relat Disord 2008; 14: 407\u2013414.","journal-title":"Dysport Benign Essential Blepharospasm Study Group"},{"key":"BFeye2009192_CR62","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1212\/01.wnl.0000311389.26145.95","volume":"70","author":"DM Simpson","year":"2008","unstructured":"Simpson DM, Blitzer A, Brashear A, Comella C, Dubinsky R, Hallett M et al. Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2008; 70: 1699\u20131706.","journal-title":"Neurology"},{"key":"BFeye2009192_CR63","first-page":"1275","volume":"71","author":"M Hallett","year":"2008","unstructured":"Hallett M, Evinger C, Jankovic J, Stacy M . BEBRF International Workshop. Update on blepharospasm: report from the BEBRF International Workshop. Neurology 2008; 71: 1275\u20131282.","journal-title":"BEBRF International Workshop"},{"key":"BFeye2009192_CR64","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1097\/ICU.0b013e3282be9032","volume":"18","author":"A Cetinkaya","year":"2007","unstructured":"Cetinkaya A, Brannan PA . What is new in the era of focal dystonia treatment? Botulinum injections and more. Curr Opin Ophthalmol 2007; 18: 424\u2013429.","journal-title":"Curr Opin Ophthalmol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/eye2009192.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye2009192","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye2009192.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:08:29Z","timestamp":1684429709000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/eye2009192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,24]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["BFeye2009192"],"URL":"https:\/\/doi.org\/10.1038\/eye.2009.192","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,24]]}}}